[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Pdr_US Pdr Pdr posts on X about $ocgn the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::18453763/interactions)  - X Week XXX +513% - X Month XXXXX +78,742% - X Months XXXXXX -XX% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::18453763/posts_active)  - X Months XX -XX% - X Year XX +8.90% ### Followers: XXXXXX [#](/creator/twitter::18453763/followers)  - X Week XXXXXX +0.07% - X Month XXXXXX +0.74% - X Months XXXXXX +2.50% - X Year XXXXXX +6.30% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::18453763/influencer_rank)  ### Social Influence [#](/creator/twitter::18453763/influence) --- **Social topic influence** [$ocgn](/topic/$ocgn) #12 ### Top Social Posts [#](/creator/twitter::18453763/posts) --- Top posts by engagements in the last XX hours "$OCGN A New Frontiers publication by Ocugen inc. Preclinical Biodistribution and Toxicology Assessment of an AAV5-Based Subretinal Modifier Gene Therapy for Retinitis Pigmentosa" [X Link](https://x.com/Pdr_US/status/1974659497911312552) [@Pdr_US](/creator/x/Pdr_US) 2025-10-05T02:14Z 13.7K followers, 2868 engagements "$OCGN OrthoCellix Logo Design Contest" [X Link](https://x.com/Pdr_US/status/1978788362610700577) [@Pdr_US](/creator/x/Pdr_US) 2025-10-16T11:41Z 13.7K followers, 1829 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Pdr posts on X about $ocgn the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social topic influence $ocgn #12
Top posts by engagements in the last XX hours
"$OCGN A New Frontiers publication by Ocugen inc. Preclinical Biodistribution and Toxicology Assessment of an AAV5-Based Subretinal Modifier Gene Therapy for Retinitis Pigmentosa"
X Link @Pdr_US 2025-10-05T02:14Z 13.7K followers, 2868 engagements
"$OCGN OrthoCellix Logo Design Contest"
X Link @Pdr_US 2025-10-16T11:41Z 13.7K followers, 1829 engagements
/creator/twitter::Pdr_US